HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity. - Wikidata - awgldk - TriplyDB

HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity.

HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity.

http://www.wikidata.org/entity/Q37372149

about

New and emerging HDAC inhibitors for cancer treatment Epigenetic regulation of endothelial-cell-mediated vascular repair Inhibition of osteogenic differentiation of human adipose-derived stromal cells by retinoblastoma binding protein 2 repression of RUNX2-activated transcription Noncoding RNAs: Possible Players in the Development of Fluorosis Histone deacetylases and cancer.Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility Proteomics analysis of human obesity reveals the epigenetic factor HDAC4 as a potential target for obesity MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation.Targeting Histone Deacetylases in Diseases: Where Are We?miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction.CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.The role for runt related transcription factor 2 (RUNX2) as a transcriptional repressor in luteinizing granulosa cells.TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma HDAC inhibitor-based therapies: can we interpret the code?Understanding developmental mechanisms in the context of osteoarthritis.Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.Metal-dependent Deacetylases: Cancer and Epigenetic Regulators Roles of RUNX in Hypoxia-Induced Responses and Angiogenesis.Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.Therapeutic applications of histone deacetylase inhibitors in sarcoma.The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets.HDAC10 promotes angiogenesis in endothelial cells through the PTPN22/ERK axis Expression characterization and the promoter activity analysis of zebrafish hdac4.HDAC inhibitor LMK‑235 promotes the odontoblast differentiation of dental pulp cells.The mechanism and potential targets of class II HDACs in angiogenesis.The effects of mid- and long-term endurance exercise on heart angiogenesis and oxidative stress

P2860

Q27022413-DC32C441-7280-4494-99D9-D01963457115 Q28085420-EA1F2BC0-93CC-4ABA-8464-CB3E4F15EA1B Q28238316-6D9648CE-43EE-48E4-B2A8-4539E49938C2 Q28385908-0D5E76E3-ACBF-4732-BE70-7C78DCBAB452 Q34298745-E8DB1BE2-69DB-46C3-A4EB-38D49BDE5EE2 Q34989177-61385D0C-D180-432F-B35C-6B94B3E583F3 Q35005577-727512BE-BB45-4FB4-BC33-795EF7AE0EDC Q35050353-702D9EC9-BAEC-4FF7-A852-E4586BAA58A4 Q35203538-319A6820-59DF-42FE-BC1E-D4737BA4C5D4 Q35821728-BED599EB-84EA-431F-80AA-7B343BB86C4A Q36068725-BBEE120D-FD46-4EEC-AE93-702BFF0EF12F Q36847079-858B31D9-7ABA-45AE-ADE3-79E96ED1BFAC Q37001222-3B5D0B1F-C7E8-4842-AC00-8D88E5FFD04F Q37395972-E979FF30-0B7D-47AC-9D23-1FC9F1BD0344 Q37396044-477DE8E0-B9DF-4A81-90DE-96C506DB7B4A Q38058971-43236E50-5633-4271-8B59-88C5A82CCCA1 Q38099555-CE5BCDD8-E662-4D3F-95F2-2AB7C93A0027 Q38402465-1E2647B6-A695-4CF4-8903-115D34422808 Q38747135-70656969-A2D0-4247-A182-062CF0BACB82 Q39181432-C69A722C-D97C-43AD-B0BD-D8B631E58F1D Q39340986-108F2E77-C9EE-4226-9361-685197EDD4CA Q39450827-58458AD8-EFA9-41F4-B4EE-D47642AC5E4D Q42084526-0199ED4C-D84C-40F9-BBF3-8D8A5888598E Q42175134-109AF6D5-8F20-4ED3-B045-1DFD0DC98783 Q42807923-994282D0-7BAA-41D6-BC60-12C582833C29 Q47401089-B7528510-FD01-4172-8C24-F8059AE48A92 Q47865822-06F0A472-4B9C-4272-94AD-6DCFEDA3991E Q58805046-4A49C13D-70FF-4006-B191-2D8DAD059984

P2860

HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity.

http://www.wikidata.org/entity/Q37372149

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HDAC4 represses vascular endot ...... by modulating RUNX2 activity.

@en

HDAC4 represses vascular endot ...... by modulating RUNX2 activity.

@nl

type

label

HDAC4 represses vascular endot ...... by modulating RUNX2 activity.

@en

HDAC4 represses vascular endot ...... by modulating RUNX2 activity.

@nl

prefLabel

HDAC4 represses vascular endot ...... by modulating RUNX2 activity.

@en

HDAC4 represses vascular endot ...... by modulating RUNX2 activity.

@nl

P1433

Q37372149-1514BF41-533E-45CA-9403-823720E8EC1E

P1476

Q37372149-870078EE-6A9E-4CDD-AA39-C7BFFBB6AD1E

P2093

Q37372149-0F269E8D-B465-422F-9C24-967687747FAB

Q37372149-1C655B02-AAFC-46DB-A70D-E8C4E7BF9F61

Q37372149-5A6FF378-B979-49ED-A61B-982E20A4DA68

Q37372149-6B412A28-CB9C-43CE-B3C2-B825A354C541

P2860

Q37372149-0230BFA6-5C3C-46EE-B19F-09D38CEB43DC

Q37372149-0ECD42BE-86CF-47EB-8664-FE84EBAA3B16

Q37372149-1803EC19-F740-4CD1-B9AA-D0A43B3B3402

Q37372149-2EE20CB9-9F64-4D5A-90EB-7CD488617166

Q37372149-33CB535F-F415-420A-9814-C4DF22F069AE

Q37372149-3B174FD3-5D6C-4FEA-BB62-D3CF62F7892B

Q37372149-3CECFF21-90CF-4916-B506-A301496CCE17

Q37372149-4648C9AC-BDA0-44C5-BF52-F7EBF6287032

Q37372149-46F1D93A-52E4-4D06-87F6-7E3A5EB174BC

Q37372149-4A05975D-8ABB-4A1C-A00D-2517491614E4

P304

Q37372149-7BFF99A6-B86C-48F3-94FE-DE15F2022179

P31

Q37372149-209C860C-2C40-471F-AA31-50F82339B211

P356

Q37372149-85A9DD23-8F33-4273-90EB-8DE157AC8F55

P407

Q37372149-7AD84C86-83E5-4CA7-A918-12B282C26426

P433

Q37372149-D90DA78F-55EC-4E60-9BE9-5E6F001CBEC9

P478

Q37372149-8D517886-5159-4A16-96CD-C9541BB7D3E9

P577

Q37372149-C743A1EC-B2FB-4B12-A7F3-3BC1F126ABAE

P698

Q37372149-015DA2D2-5ED3-43E6-AB1C-D3E0C4704842

P921

Q37372149-0298B459-5ADF-427C-BD98-58376F637090

Q37372149-EC158B25-E23C-4865-B050-89686012AFE7

P932

Q37372149-49781EF8-5F37-4E9D-ADAB-8E147D4CF83A

P356

JBC.M109.019091

P1433

Journal of Biological Chemistry

P1476

HDAC4 represses vascular endot ...... by modulating RUNX2 activity.

@en

P2093

Lei Wei

http://www.w3.org/2001/XMLSchema#string

Qian Chen

http://www.w3.org/2001/XMLSchema#string

Richard M Terek

http://www.w3.org/2001/XMLSchema#string

Xiaojuan Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Differential localization of HDAC4 orchestrates muscle differentiation

Class II histone deacetylases: versatile regulators

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Control of Smad7 stability by competition between acetylation and ubiquitination

Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation

Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis

Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.

runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins.

Dysregulation of chondrogenesis in human cleidocranial dysplasia

P304

21881-21890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M109.019091

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19509297

http://www.w3.org/2001/XMLSchema#string

P921

P932

2755912

http://www.w3.org/2001/XMLSchema#string